Unraveling the mysteries of IGF-1 signaling in melanoma

Journal of Investigative Dermatology

Volumn 128, Issue 6, 2008, Pages 1358-1360

  Lee, John T ^a   Brafford, Patricia ^a   Herlyn, Meenhard ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN BCL X; SOMATOMEDIN C; SURVIVIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULTHOOD; APOPTOSIS; CELL TYPE; DISEASE COURSE; GROWTH, DEVELOPMENT AND AGING; HUMAN; MALIGNANT TRANSFORMATION; MAMMAL; MELANOMA; MELANOMA CELL; METASTASIS; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 43749109615     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.124     Document Type: Note

References (14)

1. D.C. Altieri Survivin, cancer networks and pathway-directed drug discovery Nat Rev Cancer 8 2008 61 70
2. D.C. Bennett How to make a melanoma: what do we know of the primary clonal events? Pigment Cell Melanoma Res 21 2008 27 38
3. K.J. Cullen H.S. Smith S. Hill N. Rosen M.E. Lippman Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions Cancer Res 51 1991 4978 4985
4. D. Hanahan R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
5. H. Hartog J. Wesseling H.M. Boezen W.T. van der Graaf The insulin-like growth factor 1 receptor in cancer: old focus, new future Eur J Cancer 43 2007 1895 1904
6. C. Hilmi L. Larribere S. Giuliano K. Bille J.-P. Ortonne R. Ballotti IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivin J Invest Dermatol 128 2008 1499 1505
7. Q.S. Ji M.J. Mulvihill M. Rosenfeld-Franklin A. Cooke L. Feng G. Mak A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo Mol Cancer Ther 6 2007 2158 2167
8. L. Kanter-Lewensohn A. Dricu L. Girnita J. Wejde O. Larsson Expression of insulin-like growth factor-1 receptor (IGF-1R) and p27Kip1 in melanocytic tumors: a potential regulatory role of IGF-1 pathway in distribution of p27Kip1 between different cyclins Growth Factors 17 2000 193 202
9. E.K. Maloney J.L. McLaughlin N.E. Dagdigian L.M. Garrett K.M. Connors X.M. Zhou An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation Cancer Res 63 2003 5073 5083
10. Z.N. Oltvai C.L. Milliman S.J. Korsmeyer Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death Cell 74 1993 609 619
11. U. Rodeck K. Melber R. Kath H.D. Menssen M. Varello B. Atkinson Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes J Invest Dermatol 97 1991 20 26
12. K. Satyamoorthy G. Li B. Vaidya D. Patel M. Herlyn Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways Cancer Res 61 2001 7318 7324
13. B.F. van der Laan J.L. Freeman S.L. Asa Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues Thyroid 5 1995 67 73
14. R.J. Youle A. Strasser The BCL-2 protein family: opposing activities that mediate cell death Nat Rev 9 2008 47 59